PPD Expands Central Labs’ Preclarus® Technology

Helping Clients Accelerate and Enhance Clinical Research Decision-making

25 Jul. 2018


WILMINGTON, N.C. (July 25, 2018) – Pharmaceutical Product Development, LLC (PPD) has expanded its central lab technology capabilities integrated with Preclarus®, the comprehensive data solution that consolidates and standardizes multisource data to give clients transparent, real-time access to clinical trial operations, as well as patient and lab data. Features include a new client portal, functionality improvements for the Preclarus investigator site portal and a new companion mobile app for the investigator portal.

“The expansion of our central lab capabilities will improve the user experience for our clients and investigative sites,” said Christopher Fikry, M.D., executive vice president of PPD® Laboratories. “The innovations that Preclarus and our technology platform offer are integral to supporting our clients’ success by facilitating faster, more informed decision-making about their compounds. At the same time, we are continually expanding and enhancing our technology competencies to better support the study needs of our investigator sites.”

The features of the new client portal include visibility to real-time, studywide data and specimen information; a customizable dashboard for displaying key study metrics and tracking progress; complete sample history and chain-of-custody reports; and a variety of related tools, reports and capabilities.

The Preclarus investigator site portal enhancements include a variety of new functionalities for logistics support and chain of custody, sample storage, informed consent and reporting.

The new companion mobile app for the investigator site portal provides connectivity with iOS and Android devices that can be downloaded from the Apple App Store or Google Play, respectively; full integration of data with the web-based version in real time; and secure access to alert review and query resolution, subject registration and additional functionalities.

PPD Laboratories was recognized as a 2018 top innovator in drug development by CenterWatch, a leading publisher of clinical trials information for clinical research professionals, for the Preclarus investigator site portal and the companion mobile app, which was then still under development.

As a fully integrated component of PPD, a leading global contract research organization, PPD Laboratories offers comprehensive laboratory services, spanning bioanalytical, biomarkers, central lab, GMP and vaccine sciences.

PPD Laboratories’ central lab provides high-quality testing, results and data across a wide range of technologies and applications for all phases of pharmaceutical development. With standardized instrumentation, calibrators and reporting mechanisms, the company’s central lab locations in Asia (Singapore and Shanghai, China), Europe (Brussels, Belgium) and North America (Highland Heights, Kentucky) support clients around the world.

About PPD
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

PPD Contacts
Randy Buckwalter
+1 919 456 4425

Nate Speicher
+1 910 558 6783

Contact Us

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
Tel: +1 919 456 4425

Holly Devine Manager, Corporate Communications
Tel: +1 919 456 6389

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2020 PPD, Inc. All Rights Reserved.